Why This Landed on My Radar
The FTC just forced Ascension to divest seven surgery centers to approve their $3.9B AmSurg acquisition, and this isn’t just another healthcare M&A headline. When major health systems have to shed assets to satisfy regulators, it creates real opportunities for independent physicians who know how to move fast. If you’ve ever considered ASC ownership or partnership, pay attention - these kinds of divestitures don’t come around often.
Here’s What’s Going On
Ascension is buying AmSurg for $3.9 billion as part of a broader financial turnaround strategy, but the FTC wasn’t going to rubber-stamp a deal that consolidates this much market power. To get regulatory approval, Ascension must sell seven surgery centers before the deal can close. The health system says it’s “pleased with the compromise,” which tells you how badly they want this acquisition to happen.
The FTC’s intervention here is significant because it signals continued scrutiny of healthcare consolidation, particularly in the outpatient surgery space where margins are strong and competition matters. AmSurg is one of the largest ASC operators in the country, and combining it with Ascension’s existing footprint raised enough antitrust flags that regulators demanded divestitures. The consent order means these seven centers will hit the market, likely at prices designed to move quickly and satisfy the FTC’s timeline.
What This Means for Your Practice
Here’s what this means for us in Texas: surgery center ownership has been one of the few remaining ways independent physicians can build real equity and diversify revenue beyond fee-for-service grinding. With no Medicaid expansion and the nation’s largest uninsured population, our revenue mix is already under pressure. ASC ownership lets you capture both the professional and facility fees, and the economics can be transformational for your practice.
When major systems are forced to divest, they typically want clean, fast transactions. That can mean better terms for buyers who can move decisively. The challenge? Most independent physicians don’t have experience evaluating ASC acquisitions, negotiating with health system sellers, or structuring these deals. You need to understand payer contracting (especially with BCBS Texas and United, who dominate our commercial market), case volume projections, and how to integrate ASC ownership into your existing practice operations.
Texas has particularly strong laws protecting physician-owned ASCs, and our major metros - Houston, Dallas, Austin, San Antonio - all have robust surgical demand. But timing matters. These divestitures will attract private equity groups with deep pockets and health systems looking to expand. If you’re interested, you can’t wait for the perfect moment. You need to know what due diligence looks like, how to assess whether a center’s payer mix works for your patient population, and how to structure partnerships if you can’t or don’t want to buy solo.
The other angle: even if you’re not buying, these ownership changes affect your referral relationships. If you refer to any of these seven centers, new ownership could mean different pricing, different service lines, or changes to physician partnerships. Stay informed about who ends up buying these assets.
Key Takeaways
- Forced divestitures create acquisition opportunities - Ascension needs to sell seven surgery centers to close the AmSurg deal, and motivated sellers can mean better terms
- ASC ownership diversifies revenue beyond fee-for-service - critical in Texas where we have no Medicaid expansion and the highest uninsured rate nationally
- Speed matters when competing with PE - private equity groups are watching these divestitures too, and they can move fast with cash offers
- Due diligence is everything - payer contracts, case volume, existing physician partnerships, and facility condition all determine whether an ASC acquisition makes financial sense
- Your referral relationships may shift - even if you’re not buying, ownership changes at centers where you refer patients could affect service delivery and partnerships
What Smart Practices Are Doing
Forward-thinking physicians are building relationships with healthcare M&A advisors now, before specific opportunities hit the market, so they’re positioned to evaluate deals quickly when divestitures like this create openings. They’re also forming physician groups specifically to pool capital and expertise for ASC investments, recognizing that partnership often makes more sense than going solo.
Source
“FTC requires Ascension divestitures in $3.9B AmSurg deal” - Healthcare Dive
Primary Care Perspective delivers curated intelligence from trusted healthcare sources.
© 2026 Primary Care Perspective | Texas Edition